Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cardiovasc Toxicol. 2013 Sep;13(3):220–229. doi: 10.1007/s12012-013-9200-8

Table 1.

Role of autophagy in cardiovascular complications.

CVD Model Autophagy in the CVS Consequence(s)
Cardiac hypertrophy Inhibited
Ischemia/reperfusion Inhibited
Activated
  • Cardiomyocyte survival [81, 82]

  • Cardiomyocyte survival [83]

Heart failure Activated
  • Removal of damaged organelles [30]

  • Progressive destruction of cardiomyocytes [30, 31]

  • Adaptive mechanism to the failing heart [33]

Arrhythmias Inhibited
  • Atrial fibrillation [22]

  • Mitrial and tricuspid regurgitation [23]

  • Myolysis of cardiomyocytes [23]

Atherosclerosis Activated
  • Inhibition of autophagy leads to apoptosis of macrophages and plaque instability

  • Activation leads to VSMC death [84]

  • Over activation may lead to cell death in macrophages and VSMCs [39]

Restenosis Not determined
  • Activation of autophagy leads to inhibition of VSMC proliferation [42]

  • Activation with rapamycin prevents endothelial healing [51, 85]

Aortic aneurysm Activated
  • Activation of autophagy leads to VSMC death and rupture of vessels [43]